Sign in
4

Changes in Ownership

Tarsus Pharmaceuticals, Inc. Filed Acc 0001519692-22-000012

Chief Financial Officer sold 5,000 shares at $14.64 ($73,200)

From the SEC's structured data for this filing

Trades in this filing

Greenstein Leonard M. · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-12-15 Sale : show line 1 in the form −5,000 $14.64 $73,200 44,289 D
Open-market sales · 5,000 sh · avg $14.64 · $73,200
Loading xslF345X03/wf-form4_167122772509088.xml…